• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, November 12, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Changes to MDFA research grants evaluation process for 2023

by Staff Writer
October 13, 2022
in Local, News, Ophthalmology, Optometry, Research
Reading Time: 2 mins read
A A
A report found every dollar not spent on research is $3.32 in economic activity lost.

A report found every dollar not spent on research is $3.32 in economic activity lost.

Share on FacebookShare on Twitter

Macular Disease Foundation Australia (MDFA) has opened its 2023 research grants program, which will include a new Community Review Panel in the evaluation process for the first time.

MDFA made the announcement on World Sight Day Thursday 13 October, with next year’s grants adding to the $5.1 million it has invested in 29 projects since the research grants program was launched in 2011.

Kathy Chapman.

Applications undergo peer review and rigorous evaluation based on the National Health and Medical Research Council (NHMRC) process. New to the 2023 evaluation process will be the Community Review Panel comprising of people living with a macular condition or directly supporting those with the disease.

As MDFA’s research program is funded through public donations, this change reflects the organisation’s desire to represent the voice of the macular disease community, new CEO Dr Kathy Chapman said.

“We see this as a welcome addition to a very successful program,” she said.

“Our research program exists because our community is deeply committed to advancing understanding of this disease. We hope that the Community Review Panel will contribute to the funding decisions through their lived experience, making the research we fund even more relevant to the needs of the community, as well as being scientifically rigorous.”

The Grant Family Fund – a legacy gift in honour of the late Faye Grant and her father Ronald Grant – will again offer a total pool of up to $100,000 for early-career researchers for “blue-sky” research.

Dr Anai Gonzalez Cordero.

Dr Anai Gonzalez Cordero, from the University of Sydney, was one of the first recipients. Her project aims to create a macula-containing organoid that could be used as a source of cells for replacement therapies and to test the efficacy of potential treatments.

“This type of blue-sky thinking is very hard to get funding for – it’s seen as high-risk,” she said. But the Grant Family had vision. They wanted to fund novel ideas. This sort of creativity and new ideas and research wouldn’t be funded otherwise.”

Applications close at 5pm (AEDT) 31 January before the successful MDFA research grants applicants are announced in May 2023. To learn more about the MDFA Research Grants Program or to apply, visit here.

More reading

Early findings of Specsavers and MDFA nAMD pilot project

MDFA awards $1 million in research grants to eight projects

 

Related Posts

Essilor Stellest lens are now approved for the US market. Image: EssilorLuxottica.

Essilor Stellest lens for myopia control gains FDA approval

by Staff Writer
November 12, 2025

EssilorLuxottica has announced the US Food and Drug Administration (FDA) has granted market authorisation for its Essilor Stellest lens using...

The event will bring together leaders to address the escalating burden of childhood myopia worldwide. Image: Serhii/stock.adobe.com

HOYA to host virtual roundtable to tackle childhood myopia crisis

by Staff Writer
November 12, 2025

HOYA Vision Care will host a high-level virtual roundtable this month, spotlighting childhood myopia as a growing global health concern...

Workforce data shows orthoptists independently screen, triage, and monitor eye conditions. Image: Viacheslav Yakobchuk/stock.adobe.com.

Capturing the orthoptic workforce in 2025

by Amanda French
November 11, 2025

Orthoptics Australia’s 2025 Workforce Survey reveals critical insights into a growing, diversifying profession – addressing data gaps vital for future...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited